Latest Breaking News On - Endo international plc - Page 12 : comparemela.com

Novartis to pay $30 million to health plans, consumers over Exforge antitrust claims

By Brendan Pierson (Reuters) - Swiss drugmaker Novartis AG has agreed to pay $30 million to settle claims by health plans and consumers that it scheme.

Novartis to pay $30 million to health plans, consumers over Exforge antitrust claims

Testosterone replacement therapy market: North America to account for 58% of market growth, Driven by initiatives to increase awareness about hypogonadism among the population

/PRNewswire/ The testosterone replacement therapy market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 3.1%.

Anesthesia Drugs Market to Grow by USD 1.38 Bn, AbbVie Inc. and Baxter International Inc. Among Key Vendors

/PRNewswire/ The Anesthesia Drugs Market by Type, Route of Administration, and Geography - Forecast and Analysis - 2023-2027 report has been published by.

Novartis Pays $245 Million To Settle Exforge Drug Antitrust Cases

The swiss pharma giant Novartis has agreed to pay $245 million to resolve a lawsuit brought by three groups of plaintiffs.